NASDAQ:PGEN
Precigen, Inc.
Precigen, Inc.'s revenue grew 146.7% in fiscal 2025 to $9.7M while operating margin rose to −1141.1%, its highest in 3 years. Free cash flow was −$89.8M, −927.6% of revenue, and the diluted share count rose 16.9%.Summary generated from Precigen, Inc.'s SEC filings. Latest annual report filed Mar 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$9.7M
Revenue growth+146.7%
Revenue, 5-yr CAGR−21.3%
Gross marginn/a
Operating margin−1141.1%
Net margin−2588.2%
ROIC−188.1%
Return on equity−843.6%
Debt / equity4.46
Free cash flow−$89.8M
FCF margin−927.6%
Share count change+16.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 14 | 27 | 6 | 4 | 10 |
| Operating income | n/a | n/a | −100 | −135 | −111 |
| Net income | −92 | 28 | −96 | −126 | −251 |
| Free cash flow | −63 | −70 | −68 | −77 | −90 |
Recent filings
- 4Insider transaction report
Sep 24, 2026 - 4Insider transaction report
Aug 28, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 4, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KDirector or officer change
Jun 24, 2026 - 8-KResults of operations and financial condition
May 13, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026 - DEF 14AProxy statement
Apr 30, 2026